A May 2017 study published in The New England Journal of Medicine with individuals who have Dravet syndrome, a childhood epilepsy disorder, showed a decrease in the number of “convulsive seizures per month… from 12.4 to 5.9 with cannabidiol, as compared with a decrease from 14.9 to 14.1 with placebo.”
